missing translation for 'onlineSavingsMsg'
Learn More

Tocris Bioscience™ Upadacitinib

Numéro de catalogue. 778350
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Numéro de catalogue. Quantity
778350 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Numéro de catalogue. 778350 Fournisseur Tocris Bioscience™ Code fournisseur 7783/50
Il en reste null

JAK1-selective inhibitor

Upadacitinib is a potent and selective JAK1 inhibitor (IC50 = 47 nM). In a cellular assay, Upadacitinib shows selectivity for JAK1 over JAK2, JAK3 and TYK2 (IC50 values are 0.014 μM, 0.593 μM, 1860 μM and 2715 μM). In vivo, Upadacitinib suppresses paw swelling and bone destruction in a rat model of arthritis.

Spécifications

Chemical Name or Material (3 S,4 R)-3-Ethyl-4-(3 H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
CAS 1310726-60-3
Quantity 50 mg
Target Jak1
Molecular Formula C17H19F3N6O
Purity 0.98